CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 100 enrolled
Drug / intervention
Stress-echocardiographyother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02240745
NCT02240745N/ACompleted
CompareCT.gov

New Three-dimensional Methods of Analysis for the Detection of Coronary Artery Disease by Dobutamine Stress Echocardiography

Insel Gruppe AG, University Hospital Bern·observational·Posted Sep 16, 2014·Updated Mar 28, 2023

In Brief

An observational study evaluating Stress-echocardiography for Coronary Artery Disease and Echocardiography, Stress. Completed, enrolled 100 participants across 1 site.

Detailed Summary

The investigators are going to recruit patients who have a scheduled elective coronary angiography and going to do a dobutamin stress echography (DSE) before the coronary examination. Next to a regular 2D-DSE, the investigators will perform an 3-dimensional DSE, incl ventriculography. In the interventional part (coronary angiography), they will measure each stenosis with fractional flow-reserve (FFR)and herewith graduate its stenosis severity.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCoronary Artery Disease, Echocardiography, Stress
CountriesSwitzerland
Collaborators--

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedSep 16, 2014
Enrollment StartNov 30, 2014
Primary CompletionNov 30, 2016
TodayJul 2, 2026
Enrollment to primary: 2 yearsPosted 11.8 years ago

Interventions

Stress-echocardiographyother

Stress-echocardiography (incl dobutamin and atropin)